Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

Share Price is delayed by 15 minutes
Get Live Data
51.50    0.00 (0.00%)
Bid:
50.00
Ask:
53.00
Spread: 3.00 (6.00%)
Market Cap: £24.61m
PMP Live PriceLast checked at - London Stock Exchange

Intraday Portmeirion Share Chart

Covid-19 and Business Update

30 Mar 2020 11:25

RNS Number : 0460I
Portmeirion Group PLC
30 March 2020
 

30 March 2020

 

Portmeirion Group PLC

('the Group' or 'Portmeirion Group')

 

Covid-19 and Business Update

 

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands, announces the following business update.

Further to the announcement of the Group's preliminary results for the year ended 31 December 2019 on 19 March 2020, the Board would like to update on the impact of the Covid-19 virus and the steps we have taken to safeguard the long term health of our business.

Portmeirion Group is a well-diversified business. We sell in over 70 countries, have two UK factories and also work with premium quality sourced factories around the world.

The Board is supportive of the government's efforts to contain Covid-19 and as a Company are fully committed to following all guidance provided and instructions issued by the government and Public Health England to help reduce the spread of Covid-19. As a result and with effect from 26 March 2020, the Group's Stoke-on-Trent ceramic factory has taken a three week temporary break which includes one week of regular planned Easter holiday. The safety of our teams is paramount and we will take this time to work on implementing further safe self-distancing procedures. We have good depth of stock in our warehouses which will continue to supply our customers around the world. Although we are seeing short term order reduction from UK and US retailers due to government restrictions on retail store openings, our online sales grew strongly through March and we have a significant forward export order book. Far Eastern markets, which were first hit by the virus, are now starting to return to normal and we are pleased to be taking significant orders from our export markets. Similarly our supply chains and sourced factories in this part of the world have also resumed work.

Our UK home fragrance company Wax Lyrical has shown great endeavour in the past 10 days, converting two production lines at the Cumbria-based factory to making much needed alcohol-based hand sanitiser and spray. We will be supplying these sanitisers to local communities, care homes, the wider NHS network and pharmacists across the country. We will continue to supply regular Wax Lyrical ranges from current stock in the coming months.

Our management team has responded quickly to the challenges of the Covid-19 outbreak. Cash retention initiatives have already been implemented including delaying dividend payments, stripping back capital expenditure and cutting non-essential spend. Recent government announcements regarding 'job retention schemes' are also very beneficial to reducing our short term operational cost base. Taken altogether, the steps we have taken allow us to retain significant further cash within our business, in addition to our already committed bank facilities and headroom.

We therefore believe that, despite the uncertainty that the virus presents, the business is well positioned in the short and long term.

Once there is greater clarity on the outlook and advice from governments in the UK and US regarding retail store closures and travel restrictions we will provide further updates to the market as appropriate.

We are confident in the strength and global reach of our brands and remain committed to our long term strategy.

 

Notes: This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

ENQUIRIES:

 

Portmeirion Group PLC:

Mike Raybould

+44 (0) 1782 744 721

mraybould@portmeiriongroup.com

Chief Executive Officer

David Sproston

 

+44 (0) 1782 744 721

 

dsproston@portmeiriongroup.com

Group Finance Director

 

Hudson Sandler:

Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

Nick Moore

nmoore@hudsonsandler.com

 

Panmure Gordon

(Nominated Adviser and Broker):

 

+44 (0) 207 886 2500

Freddy Crossley / Joanna Langley

Corporate Finance

James Stearns

Corporate Broking

 

Cantor Fitzgerald Europe

(Joint Broker):

 

+44 (0) 207 894 7000

Phil Davies / Rick Thompson

Corporate Finance

Caspar Shand Kydd

Sales

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBGGDXBDXDGGG
Date   Source Headline
23rd Jun 20264:32 pmRNSPDMR Shareholdings
23rd Jun 202611:36 amRNSResult of General Meeting and Total Voting Rights
10th Jun 20267:00 amRNSResult of Retail Offer
4th Jun 20268:00 amRNSProposed Retail Offer
4th Jun 20267:00 amRNSResult of Placing and Notice of General Meeting
3rd Jun 20264:40 pmRNSProposed Placing to raise at least £15 million
2nd Jun 20261:02 pmRNSAGM Resolutions
27th May 20263:08 pmRNSExercise of Options and Total Voting Rights
21st May 20263:30 pmRNS-RStatement re Government support for UK ceramics
11th May 202610:00 amRNSConfirmation of Director Appointment
6th May 20267:01 amRNSPreliminary Results
6th May 20267:00 amRNSDirectorate change
20th Apr 202612:10 pmRNSHolding(s) in Company
27th Feb 202610:37 amRNSHolding(s) in Company
12th Feb 20263:48 pmRNSNotification of Major Holdings
12th Feb 20263:38 pmRNSNotification of Major Holdings
3rd Feb 20267:00 amRNSFY 2025 Trading Update
8th Jan 20261:03 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RSenior strategic hires
6th Oct 20251:37 pmRNSInvestor Presentation via Investor Meet Company
25th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
21st Jul 20257:00 amRNSH1 2025 TRADING UPDATE
3rd Jun 20257:00 amRNSExercise of Options, PDMR & Voting Rights
20th May 20252:24 pmRNSAGM Resolutions
11th Apr 20257:00 amRNSAnnual Report & Accounts and Notice of AGM
7th Apr 20257:00 amRNSDirector's Dealing
2nd Apr 202512:04 pmRNSDirector's Dealing
2nd Apr 20257:20 amRNSDirector's Dealing
1st Apr 202511:39 amRNSDirector's Dealing
31st Mar 20257:00 amRNSPreliminary Results
17th Mar 20257:00 amRNSNotice of Results and Investor Presentation
6th Mar 20255:14 pmRNSHolding(s) in Company
20th Jan 20257:00 amRNSAppointment of Non-Executive Chairman
20th Dec 202410:02 amRNSHolding(s) in Company
17th Dec 20247:00 amRNSHolding(s) in Company
13th Dec 20247:00 amRNSTrading Update
28th Oct 20243:07 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSAppointment to the Board
19th Sep 20247:00 amRNSInterim Results
10th Sep 20247:00 amRNSNotice of Interim Results
9th Sep 20249:40 amRNSHolding(s) in Company
6th Sep 20247:00 amRNSAppointment of Group Finance Director
18th Jul 20247:00 amRNSH1 2024 Trading update
21st May 20242:01 pmRNSAGM Resolutions
21st May 20247:00 amRNSWithdrawal of AGM Resolutions 14 and 15
8th May 20247:00 amRNSGrant of Options
17th Apr 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
4th Apr 20242:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSNotice of Investor Presentation
17th Jan 20247:00 amRNSFY23 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.